Testing effectiveness (Phase 2)Ended earlyNCT00202540
What this trial is testing
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
Who this might be right for
Mild Cognitive Impairment
Institut de Recherches Internationales Servier 38